Biochemical Engineering
Merck's Ebola vaccine gains European Commission's approval
11th November 2019
After more than two decades of research, the world finally has an approved Ebola vaccine. The European Commission granted marketing authorization to Merck’s vaccine, known as Ervebo, on Monday, less than a month after the European Medicines Agency recommended it be licensed. It is currently being used in the Democratic Republic of the Congo under a “compassionate use” or research protocol similar to a clinical trial. Source: STAT 11/11/2019
Back to group news